Both incorporate glucagon receptor agonism alongside GLP-1 activity, but retatrutide takes this further by adding a third target -- GIP receptor agonism -- making it the first triple-hormone receptor agonist in clinical development
The truth is, we dont fully know yet
But what makes semaglutide different, and how does it work
Additionally, SMGT-GLP-1 offers cardiovascular protection by reducing the risk of heart disease, improving lipid profiles, and providing anti-inflammatory effects, further protecting vascular health
No, GLP-1 meds are meant to go into the layer under the skin
In fact, partial hepatectomy induces a rapid postoperative decline of lean- and adipose tissue mass paralleled by a concomitant increase in accumulation of lipids in the regenerating liver in rodents, leading to transient steatosis 2,3